BIOLABS INTERNATIONAL LLC
UR-24, Approval for Medicare Reimbursement.
UR 24
Biolabs International LLC is an Authorized Distributor of True-Clear, UR24.
The first external catheter system which actively empties the bladder for men, women and pediatrics.
US data shows that internal catheters are associated with 80 percent of hospital-related urinary tract infections, which cost the health care system an estimated $450 million yearly. Nearly 13,000 deaths annually are related to internal catheters.
Our Revolutionary External Catheter System is Approval for Medicare Reimbursement.
Approval for Medicare Reimbursement
COMPARE AND SAVE
Cost Benefits
Cost Benefits
Cost Benefits
Compare
Cost Benefits
Cost Benefits
Why Choose UR-24
Improves Patient Quality of Life
Biolabs International LLC:
"This is a major financial step for hospitals, nursing homes, assisted-living facilities and at-home patients who will now be reimbursed for a large portion of the cost of this system the only catheter of its kind in the world which delivers the highest level of safety, efficiency, comfort and dignity to patients."